Analyst Ratings for C4 Therapeutics (CCCC)
CCCC Rating Summary
CCCC Price Target Summary
- Highest: $19.00 (BMO Capital)
- Lowest: $2.00 (BofA Securities)
- Average: $10.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.40 (+66.7%)
* Over Last 12-Mos
Rating Score: 5.8 / 10
Percentile Rank: 63%
Avg. $ Target:
$10.40 (+66.7%)
* Over Last 12-Mos
Rating Score: 5.8 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/29/2024 | JPMorgan | Eric Joseph | Upgrade | Neutral (Underweight) |
6.00 (N/A) |
5.69 (6.24) |
9.67% | Details |
| 12/13/2023 | Stifel » Updated 2/23/2024 |
Bradley Canino | Upgrade | Buy (Hold) |
13.00 (12.00) |
1.18 (6.24) |
428.81% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
